Angeion CEO departs on eve of flat Q2 results
This article was originally published in Clinica
Philip Smith, the president and CEO of cardiorespiratory diagnostic systems developer Angeion, has resigned from the company less than five months after he assumed the positions.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.